Existing data supports the notion that the druggable targets focused on in this analysis may be avenues for potentially identifying alternative therapeutic agents for inner ear diseases frequently treated with steroids, including MD, SSNHL, and AIED. Here, CACNA1F is linked to inner ear disorder.